Bisphosphonates

Ana M. Franceschi, Daniel Thomas Ginat, Jason M. Johnson

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Oral bisphosphonates are primarily used for treatment of osteoporosis and osteopenia, as well as some less common metabolic bone disorders including Paget’s disease of the bone, osteogenesis imperfecta, and fibrous dysplasia. Intravenous bisphosphonates are used for the management of cancer-related conditions, such as hypercalcemia of malignancy and skeletal complications associated with bone metastases in patients with solid tumors including breast, prostate, and lung cancer, and treatment of lytic lesions in patients with multiple myeloma.

Original languageEnglish (US)
Title of host publicationNeuroimaging Pharmacopoeia
PublisherSpringer International Publishing
Pages351-358
Number of pages8
ISBN (Electronic)9783319127156
ISBN (Print)9783319127149
DOIs
StatePublished - Jan 1 2015

ASJC Scopus subject areas

  • General Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint

Dive into the research topics of 'Bisphosphonates'. Together they form a unique fingerprint.

Cite this